Andrew A. Guirguis - Concepedia

Author

Andrew A. Guirguis

Dana-Farber Cancer Institute ORCID

Also Known As

A A Guirguis, Andrew A Guirguis, Andrew A. Guirguis, Andrew Adel Guirguis, Andrew Guirguis, Guirguis, Andrew Adel

142

Publications

Citations

H-Index

Concepts

All Affiliations

Dana-Farber Cancer Institute Broad Institute Harvard University Monash University Peter MacCallum Cancer Centre

About

Andrew A. Guirguis is an author at Dana-Farber Cancer Institute specializing in cell biology, medicine, and health sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	178
2	Cell Biology	3	3	178
3	Health Sciences	2	2	29
4	Engineering	1	1	252
5	Endocrinology	1	1	13

Andrew A. Guirguis

Publications

997

Citations

H-Index

Page 1

	Year	Citations
Small-molecule-induced polymerization triggers degradation of BCL6 Mikołaj Słabicki, Hojong Yoon, Jonas Koeppel, Nature EngineeringPolymer ScienceMolecular BiologyMacromolecular SystemPolymerization Kinetics	2020	252
Reversible ON- and OFF-switch chimeric antigen receptors controlled by lenalidomide Max Jan, Irene Scarfò, Rebecca C. Larson, Science Translational Medicine	2021	243
Non-genetic determinants of malignant clonal fitness at single-cell resolution Katie Fennell, Dane Vassiliadis, Enid Y.N. Lam, Nature Malignant Clonal FitnessTumor HeterogeneityMedicineCancer GeneticsSingle-cell Analysis	2021	149
Crbn I391V is sufficient to confer in vivo sensitivity to thalidomide and its derivatives in mice Emma C. Fink, Marie McConkey, Dylan N. Adams, Blood	2018	117
Inhibition of METTL3 Results in a Cell-Intrinsic Interferon Response That Enhances Antitumor Immunity Andrew A. Guirguis, Yaara Ofir-Rosenfeld, Kathy Knezevic, Cancer Discovery	2023	100
Systematic profiling of conditional degron tag technologies for target validation studies Daniel P. Bondeson, Zachary Mullin-Bernstein, Sydney Oliver, Nature Communications	2022	47
Avadomide Induces Degradation of ZMYM2 Fusion Oncoproteins in Hematologic Malignancies Aline Renneville, Jessica A. Gasser, Daniel E. Grinshpun, Blood Cancer Discovery	2021	41
Restricted cell cycle is essential for clonal evolution and therapeutic resistance of pre-leukemic stem cells Cédric S. Tremblay, Jesslyn Saw, Sung Kai Chiu, Nature Communications	2018	19
PUMA promotes apoptosis of hematopoietic progenitors driving leukemic progression in a mouse model of myelodysplasia Andrew A. Guirguis, Christopher Slape, Laura M. Failla, Cell Death and Differentiation Hematological MalignancyHematopoietic ProgenitorsApoptosisHematologyImmunology	2016	16
Leptin-deficient obesity prolongs survival in a murine model of myelodysplastic syndrome Michael J. Kraakman, Hélène L. Kammoun, Dragana Dragoljevic, Haematologica Metabolic DisorderBone Marrow TransplantImmunologyPathologyMyeloid Cells	2018	13

Page 1